| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |